Cargando…

P591: EXPRESSION PATTERNS AND CLINICAL RELEVANCE OF IMMUNE CHECKPOINT RECEPTORS AND LIGANDS IN ACUTE MYELOID LEUKEMIA

Detalles Bibliográficos
Autores principales:	Jagurinoski, Milan, Vladimirova, Rositsa, Muhtarova, Maria, Stojcov-Jagurinoska, Milena, Guenova, Margarita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429297/ http://dx.doi.org/10.1097/01.HS9.0000969268.93457.2f

Ejemplares similares

PB1823: SECONDARY ACUTE MYELOID LEUKEMIA AND DE NOVO ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES DISTINCT LANDSCAPE, OR THE SAME DISEASE?
por: Jagurinoski, M., et al.
Publicado: (2022)

PB2175: TRYPAN BLUE AND FLOW CYTOMETRY CELL VIABILITY TESTING OF PACKED OR DILUTED CRYOPRESERVED AT -80ºC HEMATOPOIETIC STEM CELLS SHOW SIMILAR RESULTS
por: Tonev, I., et al.
Publicado: (2022)

Expression patterns of immune checkpoints in acute myeloid leukemia
por: Chen, Cunte, et al.
Publicado: (2020)

591. A Model for assessing staffing needs for an Outpatient Parenteral Antibiotic Therapy (OPAT) program
por: Munsiff, Sonal, et al.
Publicado: (2020)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

591 The association between COVID-19 related health services changes and postpartum contraception
por: Sakowicz, Allie, et al.
Publicado: (2021)

Correlation between the type of bcr-abl transcripts and blood cell counts in chronic myeloid leukemia – a possible influence of mdr1 gene expression
por: Balatzenko, Gueorgui, et al.
Publicado: (2011)

Checkpoint Inhibitors in Acute Myeloid Leukemia
por: Damiani, Daniela, et al.
Publicado: (2023)

591. Comparison of Fluconazole to Other Antifungal Agents in Allogeneic Hematopoietic Cell Transplant Recipients: A Meta-Analysis of Randomized Clinical Trials
por: Cheng, Ce, et al.
Publicado: (2021)

P453: NOVEL INSIGHTS INTO MINIMAL RESIDUAL DISEASE OF ACUTE MYELOID LEUKEMIA USING PRIMARY SAMPLES AND A CLINICALLY RELEVANT PDX MODEL.
por: Aroua, Nesrine, et al.
Publicado: (2023)

P673: ASCIMINIB MANAGMENT IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH T315I MUTATION.
por: Kuzmina, Elena, et al.
Publicado: (2023)

P677: THE FACTORS OF LATE MOLECULAR RELAPSES AFTER TYROSINE KINASE INHIBITORS DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
por: Petrova, Anna, et al.
Publicado: (2023)

SUN-591 Severe Iron-Deficiency Anemia Leading to Hypothyroidism
por: Ghiya, Ronak, et al.
Publicado: (2019)

MON-591 Effect of Liraglutide Treatment on Proglucagon-Derived Peptides
por: Kim, Sun, et al.
Publicado: (2020)

P515: A REAL-WORLD EVALUATION OF TREATMENT PATTERNS AND OUTCOMES OF ACUTE MYELOID LEUKEMIA INDUCTION THERAPIES IN THE COMMUNITY SETTING
por: Maher, Keri, et al.
Publicado: (2023)

Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia
por: Giannopoulos, Krzysztof
Publicado: (2019)

P424: LANDSCAPE OF CHROMATIN ACCESSIBILITY IN ACUTE MYELOID LEUKEMIA
por: Ochi, Yotaro, et al.
Publicado: (2023)

Histone methylation modification patterns and relevant M-RiskScore in acute myeloid leukemia()
por: Rong, Dade, et al.
Publicado: (2022)

Are different hydroxyethyl starch solutions an independent risk factor for acute kidney injury in surgical critically ill patients? A retrospective analysis of 3,591 patients
por: Ertmer, C, et al.
Publicado: (2010)

The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
por: Williams, Patrick, et al.
Publicado: (2018)

591 A Case of Idiopathic Recurrent Isolated Orbital Angioedema with Exophthalmos
por: Talreja, Neetu, et al.
Publicado: (2012)

FRI591 Association Of TSH Levels And NAFLD Severity In Children And Adolescents
por: Untalan, Matthew, et al.
Publicado: (2023)

P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
por: Lachowiez, Curtis, et al.
Publicado: (2023)

P513: MOLECULAR PATTERN BY AGE AND OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA: A POPULATION-BASED STUDY FROM THE SWEDISH AML REGISTRY.
por: Juliusson, Gunnar, et al.
Publicado: (2023)

P527: DISTINCTIVE CLONAL EVOLUTION PATTERN AND PROGNOSTIC SIGNIFICANCE OF THE CLONALITY OF KRAS MUTATIONS IN KMT2A-REARRANGED ACUTE MYELOID LEUKEMIA
por: Matsuo, Hidemasa, et al.
Publicado: (2023)

Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance
por: Zhu, Yong-Mei, et al.
Publicado: (2017)

NPM1 Gene Type A Mutation in Bulgarian Adults with Acute Myeloid Leukemia: A Single-Institution Study
por: Balatzenko, Gueorgui, et al.
Publicado: (2014)

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Abaza, Yasmin, et al.
Publicado: (2022)

P682: THE RESULTS OF THE RUSSIAN PROSPECTIVE STUDY OF REDUCTION AND DISCONTINUATION TREATMENT OF TKI (READIT-2020) IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE
por: Gurianova, Margarita, et al.
Publicado: (2023)

P1398: INSIGHT INTO ACUTE MYELOID LEUKEMIA INDUCED MSC SECRETOME TO REROUTE THE COURSE OF LEUKEMIA BONE MARROW NICHE
por: Borella, G., et al.
Publicado: (2022)

P420: THE ROLE OF ACETYLCHOLINE IN THE REGULATION OF ACUTE MYELOID LEUKEMIA STEM CELLS
por: Buri, Michelle, et al.
Publicado: (2023)

P478: MOLECULAR CHARACTERIZATION OF EXTRAMEDULLARY LOCALIZATIONS IN ACUTE MYELOID LEUKEMIA (AML)
por: Silvestrini, Giorgia, et al.
Publicado: (2023)

P476: AN ORAL COMBINATION THERAPY OF OR-2100 AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
por: Kamachi, Kazuharu, et al.
Publicado: (2023)

P474: FUNCTIONAL (PHOSPHO-)PROTEOMICS OF DRUG RESPONSE IN ACUTE MYELOID LEUKEMIA
por: Oliinyk, Denys, et al.
Publicado: (2023)

P696: DYNAMICS OF CLONAL EVOLUTION IN CHRONIC MYELOMONOCYTIC LEUKEMIA WITH PROGRESSION TO SECONDARY ACUTE MYELOID LEUKEMIA: PAIRED-SAMPLE COMPARISON
por: Kao, Hsiao-Wen, et al.
Publicado: (2023)

P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
por: Lam Ngai, Lok, et al.
Publicado: (2023)

Recombinant trail: a synergistic effect in myeloid leukemias
por: Carvalho, Filipa, et al.
Publicado: (2010)

Molecular Epidemiology in 591 Italian Probands With Nonsyndromic Retinitis Pigmentosa and Usher Syndrome
por: Colombo, Leonardo, et al.
Publicado: (2021)

(591) Prolonged V.v.-Ecmo for Covid-19 Ards with Lung Recovery
por: Beckett, A., et al.
Publicado: (2023)

P450: ALDH1A AS A THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA
por: Shaikh, Mehak, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j9s22psotlh6fgtlp54vq4ot4f